PL1748985T3 - Cykliczne pochodne amidowe i ich wytwarzanie oraz zastosowanie jako środków przeciwzakrzepowych - Google Patents

Cykliczne pochodne amidowe i ich wytwarzanie oraz zastosowanie jako środków przeciwzakrzepowych

Info

Publication number
PL1748985T3
PL1748985T3 PL05743594T PL05743594T PL1748985T3 PL 1748985 T3 PL1748985 T3 PL 1748985T3 PL 05743594 T PL05743594 T PL 05743594T PL 05743594 T PL05743594 T PL 05743594T PL 1748985 T3 PL1748985 T3 PL 1748985T3
Authority
PL
Poland
Prior art keywords
optionally substituted
cyclic amide
bond
production
amide derivatives
Prior art date
Application number
PL05743594T
Other languages
English (en)
Inventor
K Kubo
Y Imaeda
Original Assignee
Takeda Pharmaceuticals Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Takeda Pharmaceuticals Co filed Critical Takeda Pharmaceuticals Co
Publication of PL1748985T3 publication Critical patent/PL1748985T3/pl

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/68Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
    • C07D211/72Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D211/74Oxygen atoms
    • C07D211/76Oxygen atoms attached in position 2 or 6
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/04Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/04Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/04Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Urology & Nephrology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Pyrrole Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
PL05743594T 2004-05-21 2005-05-20 Cykliczne pochodne amidowe i ich wytwarzanie oraz zastosowanie jako środków przeciwzakrzepowych PL1748985T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2004152000 2004-05-21
EP05743594A EP1748985B1 (en) 2004-05-21 2005-05-20 Cyclic amide derivatives, and their production and use as antithrombotic agents
PCT/JP2005/009711 WO2005113504A1 (en) 2004-05-21 2005-05-20 Cyclic amide derivatives, and their production and use as antithrombotic agents

Publications (1)

Publication Number Publication Date
PL1748985T3 true PL1748985T3 (pl) 2011-11-30

Family

ID=34968275

Family Applications (1)

Application Number Title Priority Date Filing Date
PL05743594T PL1748985T3 (pl) 2004-05-21 2005-05-20 Cykliczne pochodne amidowe i ich wytwarzanie oraz zastosowanie jako środków przeciwzakrzepowych

Country Status (26)

Country Link
US (4) US7745623B2 (pl)
EP (2) EP2208726B1 (pl)
JP (2) JP4129047B2 (pl)
KR (1) KR101248637B1 (pl)
CN (2) CN102093285B (pl)
AT (1) ATE513813T1 (pl)
AU (1) AU2005245298B2 (pl)
BR (1) BRPI0511186A (pl)
CA (1) CA2567506C (pl)
CY (1) CY1111850T1 (pl)
DK (1) DK1748985T3 (pl)
ES (1) ES2368155T3 (pl)
HR (1) HRP20110640T1 (pl)
IL (1) IL178896A (pl)
MX (1) MXPA06013243A (pl)
MY (1) MY154461A (pl)
NO (1) NO20065929L (pl)
NZ (1) NZ550985A (pl)
PH (1) PH12012501331A1 (pl)
PL (1) PL1748985T3 (pl)
PT (1) PT1748985E (pl)
RS (1) RS51925B (pl)
RU (1) RU2361861C2 (pl)
SI (1) SI1748985T1 (pl)
TW (1) TWI396686B (pl)
WO (1) WO2005113504A1 (pl)

Families Citing this family (70)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2001269531A1 (en) * 2000-07-17 2002-01-30 Takeda Chemical Industries Ltd. Sulfone derivatives, process for their production and use thereof
US20070004736A1 (en) * 2002-11-22 2007-01-04 Keiji Kubo Imidazole derivative, process for producing the same, and use
TWI396686B (zh) * 2004-05-21 2013-05-21 Takeda Pharmaceutical 環狀醯胺衍生物、以及其製品和用法
CA2632218A1 (en) * 2005-11-28 2007-10-11 Zymogenetics, Inc. Il-21 receptor antagonists
US20110045028A1 (en) * 2006-11-30 2011-02-24 Takeda Pharmaceutical Company Limited Sustained release preparation
UY32126A (es) 2008-09-25 2010-04-30 Takeda Pharmaceutical Composición farmacéutica sólida
US8501804B2 (en) 2008-10-27 2013-08-06 Takeda Pharmaceutical Company Limited Bicyclic compound
WO2010076884A1 (ja) 2008-12-29 2010-07-08 武田薬品工業株式会社 新規縮合環化合物およびその用途
WO2010087467A1 (en) 2009-01-27 2010-08-05 Takeda Pharmaceutical Company Limited Delta-5-desaturase inhibitors
GEP20135940B (en) 2009-04-30 2013-10-10 Takeda Pharmaceuticals Co Solid preparations
WO2010143733A1 (en) 2009-06-09 2010-12-16 Takeda Pharmaceutical Company Limited Novel fused cyclic compound and use thereof
CA2769177A1 (en) 2009-07-28 2011-02-03 Takeda Pharmaceutical Company Limited Tablet
US8221489B2 (en) * 2009-08-20 2012-07-17 Stentys Device and method for treating a body lumen
UA108102C2 (uk) 2010-04-27 2015-03-25 Біциклічні похідні і їх застосування як інгібіторів асс
UA108888C2 (xx) 2010-06-16 2015-06-25 Кристал аміду
EP2597095A4 (en) 2010-07-23 2014-10-01 Takeda Pharmaceutical CONDENSED HETEROCYCLIC COMPOUND AND ITS USE
WO2012036293A1 (ja) 2010-09-17 2012-03-22 武田薬品工業株式会社 糖尿病治療剤
KR20140001965A (ko) 2010-11-30 2014-01-07 다케다 야쿠힌 고교 가부시키가이샤 바이시클릭 화합물
AU2012218401A1 (en) 2011-02-17 2013-09-05 Takeda Pharmaceutical Company Limited Production method of optically active dihydrobenzofuran derivative
CN103998432A (zh) 2011-10-24 2014-08-20 武田药品工业株式会社 双环化合物
JP6129850B2 (ja) 2012-01-12 2017-05-17 武田薬品工業株式会社 Mch受容体拮抗剤としてのベンゾイミダゾール誘導体
US9382188B2 (en) 2012-02-13 2016-07-05 Takeda Pharmaceutical Company Limited Aromatic ring compound
JP6121339B2 (ja) 2012-02-13 2017-04-26 武田薬品工業株式会社 芳香環化合物
CA2864068A1 (en) 2012-02-15 2013-08-22 Takeda Pharmaceutical Company Limited Tablet comprising 1-(4-methoxybutyl)-n-(2-methylpropyl)-n-[(3s,5r)-5-(morpholin-4-ylcarbonyl)piperidin-3-yl]-1h-benzimidazole-2-carboxamide or a salt thereof
WO2013125732A1 (en) 2012-02-24 2013-08-29 Takeda Pharmaceutical Company Limited Aromatic ring compound
WO2013147026A1 (ja) 2012-03-29 2013-10-03 武田薬品工業株式会社 芳香環化合物
EP2848621A4 (en) 2012-05-10 2016-06-01 Takeda Pharmaceutical AROMATIC RING CONNECTION
WO2013168760A1 (ja) 2012-05-10 2013-11-14 武田薬品工業株式会社 芳香環化合物
AR092843A1 (es) 2012-06-05 2015-05-06 Takeda Pharmaceuticals Co Preparacion solida
JP2015127299A (ja) 2012-07-19 2015-07-09 武田薬品工業株式会社 固形製剤
WO2014030743A1 (ja) 2012-08-24 2014-02-27 武田薬品工業株式会社 複素環化合物
CN103936763B (zh) * 2013-01-18 2017-10-31 中国科学院上海药物研究所 噁唑烷酮类化合物及其制备方法和用途
US9605000B2 (en) 2013-03-14 2017-03-28 Takeda Pharmaceutical Company Limited Spiro azetidine isoxazole derivatives and their use as SSTR antagonists
US10005720B2 (en) 2013-04-05 2018-06-26 North Carolina Central University Compounds useful for the treatment of metabolic disorders and synthesis of the same
JP2016523809A (ja) 2013-07-09 2016-08-12 武田薬品工業株式会社 複素環化合物
LT3031799T (lt) 2013-08-09 2018-06-25 Takeda Pharmaceutical Company Limited Aromatinis junginys
JO3442B1 (ar) 2013-10-07 2019-10-20 Takeda Pharmaceuticals Co مضادات ذات نوع فرعي من مستقبل سوماتوستاتين 5 (sstr5)
US9346776B2 (en) 2014-02-13 2016-05-24 Takeda Pharmaceutical Company Limited Fused heterocyclic compound
US9428470B2 (en) 2014-02-13 2016-08-30 Takeda Pharmaceutical Company Limited Heterocyclic compound
RU2672257C2 (ru) * 2014-09-26 2018-11-13 Чанчжоу Иньшэн Фармасьютикал Ко., Лтд. Аналог бензофурана в качестве ингибитора ns4b
ES2829675T3 (es) 2014-12-23 2021-06-01 Crossing S R L Reactivos que comprenden 2-halo-4,6-dialcoxi-1,3,5-triazinas en presencia de aminas y su uso en un método de estabilización
US11186565B2 (en) 2017-03-31 2021-11-30 Takeda Pharmaceutical Company Limited Aromatic compound
AR111199A1 (es) 2017-03-31 2019-06-12 Takeda Pharmaceuticals Co Compuesto aromático agonista de gpr40
JOP20180028A1 (ar) 2017-03-31 2019-01-30 Takeda Pharmaceuticals Co مركب ببتيد
WO2019018186A1 (en) 2017-07-17 2019-01-24 Merck Sharp & Dohme Corp. Metallo-beta-lactamase inhibitors and methods of use thereof
MX2020009950A (es) 2018-03-23 2021-04-28 Carmot Therapeutics Inc Moduladores de receptores acoplados a proteina g.
WO2020045326A1 (ja) 2018-08-27 2020-03-05 株式会社スコヒアファーマ 安息香酸エステル化合物
EP3856339A1 (en) 2018-09-24 2021-08-04 Takeda Pharmaceutical Company Limited Gip receptor agonist peptide compounds and uses thereof
EP3856768A2 (en) 2018-09-24 2021-08-04 Takeda Pharmaceutical Company Limited Gip receptor agonist peptide compounds and uses thereof
PL4097099T3 (pl) 2020-02-07 2024-11-04 Gasherbrum Bio, Inc. Heterocykliczne agonisty glp-1
PH12022552562A1 (en) 2020-03-25 2022-12-19 Takeda Pharmaceuticals Co Qd dosing of gip receptor agonist peptide compounds and uses thereof
CN115916812A (zh) 2020-03-25 2023-04-04 武田药品工业株式会社 Gip受体激动剂肽化合物及其用途
CR20230530A (es) 2021-05-13 2024-02-19 Carmot Therapeutics Inc Moduladores de los receptores acoplados a proteínas g.
WO2023169456A1 (en) 2022-03-09 2023-09-14 Gasherbrum Bio , Inc. Heterocyclic glp-1 agonists
EP4496797A1 (en) 2022-03-21 2025-01-29 Gasherbrum Bio, Inc. 5,8-dihydro-1,7-naphthyridine derivatives as glp-1 agonists for the treatment of diabetes
JP2025513071A (ja) 2022-04-14 2025-04-22 ガシャーブラム・バイオ・インコーポレイテッド ヘテロ環式glp-1アゴニスト
EP4634180A1 (en) 2022-12-15 2025-10-22 Gasherbrum Bio, Inc. Salts and solid forms of a compound having glp-1 agonist activity
WO2024138048A1 (en) 2022-12-22 2024-06-27 Gasherbrum Bio, Inc. Heterocyclic glp-1 agonists
EP4638440A1 (en) 2022-12-22 2025-10-29 Gasherbrum Bio, Inc. Heterocyclic glp-1 agonists
IL322686A (en) 2023-02-16 2025-10-01 Gasherbrum Bio Inc Heterocyclic glp-1 agonists
TW202506102A (zh) 2023-06-30 2025-02-16 美商迦舒布魯姆生物有限公司 雜環的glp-1促效劑
WO2025015269A1 (en) 2023-07-13 2025-01-16 Aconcagua Bio, Inc. Compounds, compositions, and methods
AR133240A1 (es) 2023-07-13 2025-09-10 Aconcagua Bio Inc Compuestos, composiciones y métodos
WO2025045208A1 (en) 2023-08-31 2025-03-06 Gasherbrum Bio, Inc. Heteroaryl-heterocycloalkyl-based glp-1 agonists
WO2025137307A1 (en) 2023-12-20 2025-06-26 Gasherbrum Bio, Inc. Heterocyclic glp-1 agonists
WO2025154021A1 (en) 2024-01-19 2025-07-24 Takeda Pharmaceutical Company Limited Improved gip receptor agonist peptide compounds and uses thereof
WO2025154020A1 (en) 2024-01-19 2025-07-24 Takeda Pharmaceutical Company Limited Improved gip receptor agonist peptide compounds and uses thereof
WO2025171341A2 (en) 2024-02-08 2025-08-14 Aconcagua Bio, Inc. Compounds and compositions for treating conditions associated with calcitonin receptor and/or amylin receptor activity
WO2025171340A1 (en) 2024-02-08 2025-08-14 Aconcagua Bio, Inc. The treatment of calcitonin- and/or amylin-receptor associated conditions
WO2025189141A1 (en) 2024-03-08 2025-09-12 Annapurna Bio, Inc. Methods for treating obesity and increasing weight loss

Family Cites Families (87)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US270488A (en) * 1883-01-09 Drilling apparatus
US2201270A (en) * 1936-04-17 1940-05-21 Mcintyre John Taylor Apparatus for allaying dust from rock drills
US2946565A (en) * 1953-06-16 1960-07-26 Jersey Prod Res Co Combination drilling and testing process
US2849214A (en) * 1954-09-02 1958-08-26 Gulf Research Development Co Borehole drilling apparatus for preventing lost circulation
US3497020A (en) * 1968-05-20 1970-02-24 Archer W Kammerer Jr System for reducing hydrostatic pressure on formations
JPS5011391B1 (pl) * 1970-07-21 1975-04-30
SE355840B (pl) * 1971-09-08 1973-05-07 Atlas Copco Ab
FR2228301B1 (pl) 1973-05-03 1977-10-14 Ibm
US4147786A (en) 1976-02-02 1979-04-03 Ciba-Geigy Corporation 1-Indolylalkyl-3-or 4-trimethyleneurido-piperidines
FI782133A7 (fi) * 1977-07-08 1979-01-09 Ciba Geigy Ag Piperidino-propanoler och foerfarande foer deras framstaellning
EP0000485A1 (de) 1977-07-08 1979-02-07 Ciba-Geigy Ag Piperidino-propanole, ihre Herstellung und pharmazeutische Präparate die diese enthalten
US4329348A (en) 1979-02-26 1982-05-11 Ciba-Geigy Corporation N-Oxacyclic-alkylpiperidines as psychostimulants
US4630691A (en) * 1983-05-19 1986-12-23 Hooper David W Annulus bypass peripheral nozzle jet pump pressure differential drilling tool and method for well drilling
US4534426A (en) * 1983-08-24 1985-08-13 Unique Oil Tools, Inc. Packer weighted and pressure differential method and apparatus for Big Hole drilling
US4567954A (en) * 1983-12-02 1986-02-04 Norton Christensen, Inc. Replaceable nozzles for insertion into a drilling bit formed by powder metallurgical techniques and a method for manufacturing the same
US4695575A (en) 1984-11-13 1987-09-22 Janssen Pharmaceutica, N.V. 4-[(bicycle heterocyclyl)-methyl and -hetero]-piperidines
ZA928276B (en) 1991-10-31 1993-05-06 Daiichi Seiyaku Co Aromatic amidine derivates and salts thereof.
US5902272A (en) 1992-01-07 1999-05-11 Arthrocare Corporation Planar ablation probe and method for electrosurgical cutting and ablation
US5595872A (en) * 1992-03-06 1997-01-21 Bristol-Myers Squibb Company Nucleic acids encoding microsomal trigyceride transfer protein
HU218419B (hu) 1992-03-06 2000-08-28 E.R. Squibb And Sons, Inc. Mikroszomális triglicerid transzfer protein (MTP) nagy molekulatömegű alegységének rekombináns úton történő előállítására és a protein és inhibitorainak kimutatására szolgáló eljárások
US5355967A (en) * 1992-10-30 1994-10-18 Union Oil Company Of California Underbalance jet pump drilling method
GB9321557D0 (en) 1992-11-03 1993-12-08 Zeneca Ltd Carboxamide derivatives
GB9312806D0 (en) 1993-06-22 1993-08-04 Boots Co Plc Therapeutic agents
GB9317104D0 (en) * 1993-08-17 1993-09-29 Zeneca Ltd Therapeutic heterocycles
TW394760B (en) 1993-09-07 2000-06-21 Hoffmann La Roche Novel Carboxamides, process for their preparation and pharmaceutical composition containing the same
IL112795A (en) * 1994-03-04 2001-01-28 Astrazeneca Ab Peptide derivatives as antithrombic agents their preparation and pharmaceutical compositions containing them
US5456326A (en) * 1994-04-18 1995-10-10 Exxon Production Research Company Apparatus and method for installing open-ended tubular members axially into the earth
IL115420A0 (en) 1994-09-26 1995-12-31 Zeneca Ltd Aminoheterocyclic derivatives
JP2002515008A (ja) 1994-10-27 2002-05-21 メルク エンド カンパニー インコーポレーテッド ムスカリン・アンタゴニスト
PT798295E (pt) 1994-12-02 2003-07-31 Yamanouchi Pharma Co Ltd Novo derivado de amidinonaftilo ou sal deste
GB9508786D0 (en) 1995-04-29 1995-06-21 Zeneca Ltd Substituted heterocycles
MX9709278A (es) * 1995-05-29 1998-03-31 Pfizer Dipeptidos que promueven la liberacion de la hormona de crecimiento, composiciones que los contienen y uso de los mismos.
US5612353A (en) 1995-06-07 1997-03-18 Rhone-Poulenc Rorer Pharmaceuticals Inc. Substituted (sulfinic acid, sulfonic acid, sulfonylamino or sulfinylamino) N-[(aminoiminomethyl)phenylalkyl]-azaheterocyclylamide compounds
US5849759A (en) 1995-12-08 1998-12-15 Berlex Laboratories, Inc. Naphthyl-substituted benzimidazole derivatives as anti-coagulants
GB9602294D0 (en) 1996-02-05 1996-04-03 Zeneca Ltd Heterocyclic compounds
AP1390A (en) 1996-11-27 2005-04-15 Aventis Pharmaceuticals Products Inc Pharmaceutical composition comprising a compound having anti-Xa activity and a platelet aggregation antagonist compound.
WO1998054164A1 (en) 1997-05-30 1998-12-03 Takeda Chemical Industries, Ltd. Sulfonamide derivatives, their production and use
FR2764511B1 (fr) 1997-06-13 2000-09-08 Sanofi Sa Compositions pour le traitement et la prevention de la thrombose arterielle et utilisation d'un inhibiteur du facteur xa seul et/ou en combinaison avec un antiagregant plaquettaire
GB9715895D0 (en) 1997-07-29 1997-10-01 Zeneca Ltd Heterocyclic compounds
US6348478B1 (en) 1997-11-20 2002-02-19 Teijin Limited Biphenylamidine derivatives
KR20010074420A (ko) 1997-11-21 2001-08-04 둘락 노먼 씨. 뉴로키닌 길항제로서의 치환된 옥심
AU1692399A (en) 1997-12-26 1999-07-19 Mochida Pharmaceutical Co., Ltd. Aromatic compounds having cyclic amino or salts thereof
CA2317017A1 (en) 1998-02-05 1999-08-12 Takeda Chemical Industries, Ltd. Sulfonamide derivatives, their production and use
NZ508101A (en) 1998-04-10 2002-12-20 Japan Tobacco Inc Amidine compounds useful as factor Xa inhibitors and as anticoagulants
US6129152A (en) * 1998-04-29 2000-10-10 Alpine Oil Services Inc. Rotating bop and method
GB9809349D0 (en) 1998-05-02 1998-07-01 Zeneca Ltd Heterocyclic derivatives
US6423519B1 (en) * 1998-07-15 2002-07-23 Gpc Biotech Inc. Compositions and methods for inhibiting fungal growth
CA2340100A1 (en) 1998-08-11 2000-02-24 Daiichi Pharmaceutical Co., Ltd. Novel sulfonyl derivatives
JP2000080046A (ja) 1998-09-03 2000-03-21 Dai Ichi Seiyaku Co Ltd 多臓器障害の予防・治療剤
CA2345273A1 (en) 1998-09-25 2000-04-06 Sunol Molecular Corporation Pharmaceutically active compounds and methods of use thereof
US6204265B1 (en) 1998-12-23 2001-03-20 Schering Corporation Substituted oximes and hydrazones as neurokinin antagonists
ATE277035T1 (de) 1998-12-23 2004-10-15 Schering Corp Substituierte oxime und hydrazone als neurokinin antagonisten
US7217714B1 (en) * 1998-12-23 2007-05-15 Agouron Pharmaceuticals, Inc. CCR5 modulators
WO2000078747A1 (en) 1999-06-22 2000-12-28 Takeda Chemical Industries, Ltd. Acylhydrazine derivatives, process for preparing the same and use thereof
NZ516363A (en) 1999-06-30 2004-05-28 Mochida Pharm Co Ltd Tricyclic compounds having spiro union having FXa inhibitory activity
JP4829449B2 (ja) 1999-07-28 2011-12-07 アベンティス・ファーマスーティカルズ・インコーポレイテツド 置換オキソアザヘテロシクリル化合物
AU7354900A (en) 1999-09-09 2001-04-10 Merck & Co., Inc. Inhibitors of prenyl-protein transferase
EP1242366A1 (en) 1999-12-15 2002-09-25 Axys Pharmaceuticals, Inc. Salicylamides as serine protease and factor xa inhibitors
US6629974B2 (en) 2000-02-22 2003-10-07 Gyrus Medical Limited Tissue treatment method
US6723091B2 (en) 2000-02-22 2004-04-20 Gyrus Medical Limited Tissue resurfacing
AR033517A1 (es) 2000-04-08 2003-12-26 Astrazeneca Ab Derivados de piperidina, proceso para su preparacion y uso de estos derivados en la fabricacion de medicamentos
AU2001269531A1 (en) * 2000-07-17 2002-01-30 Takeda Chemical Industries Ltd. Sulfone derivatives, process for their production and use thereof
JP2002201178A (ja) * 2000-07-17 2002-07-16 Takeda Chem Ind Ltd スルホン誘導体、その製造法及び用途
US6511973B2 (en) 2000-08-02 2003-01-28 Bristol-Myers Squibb Co. Lactam inhibitors of FXa and method
EP1322610A2 (en) 2000-09-29 2003-07-02 Millennium Pharmaceuticals, Inc. PIPERAZINE BASED INHIBITORS OF FACTOR Xa
DK1331892T3 (da) 2000-10-18 2006-10-30 Mattioli Eng Ltd Apparat til resurfacing af hud ved hjælp af plasma
FR2819511A1 (fr) 2001-01-18 2002-07-19 Servier Lab Nouveaux composes azepane, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
JPWO2002068407A1 (ja) 2001-02-28 2004-06-24 山之内製薬株式会社 ベンゾイミダゾール化合物
ATE384713T1 (de) 2001-07-26 2008-02-15 Lilly Co Eli 1-glycinyl-4-(1-methylpiperidin-4-yl)piperazine und -piperidine als faktor-xa-antagonisten
US6877571B2 (en) * 2001-09-04 2005-04-12 Sunstone Corporation Down hole drilling assembly with independent jet pump
US7115741B2 (en) 2001-09-06 2006-10-03 Levy Daniel E 4-thieno[2,3-D]pyrimidin-4-YL piperazine compounds
GEP20074098B (en) 2001-09-21 2007-05-10 Bristol Myers Squibb Co Lactam-containing compounds and derivatives thereof as factor xa inhibitors
WO2003031432A1 (en) * 2001-10-12 2003-04-17 Novo Nordisk A/S Substituted piperidines and their use for the treatment of diseases related to the histamine h3 receptor
DE10155075A1 (de) 2001-11-09 2003-05-22 Merck Patent Gmbh Cyclische Sulfonamide
PT1489078E (pt) 2002-03-28 2010-02-24 Mitsubishi Tanabe Pharma Corp Derivados de benzofurano
TW200307667A (en) 2002-05-06 2003-12-16 Bristol Myers Squibb Co Sulfonylaminovalerolactams and derivatives thereof as factor Xa inhibitors
DE10229070A1 (de) 2002-06-28 2004-01-15 Merck Patent Gmbh Phenylderivate 5
US20040006490A1 (en) 2002-07-08 2004-01-08 Gingrich Mark A. Prescription data exchange system
WO2004031145A2 (en) 2002-10-02 2004-04-15 Bristol-Myers Squibb Company Lactam-containing diaminoalkyl, beta-aminoacids, alpha-aminoacids and derivatives thereof as factor xa inhibitors
WO2004035579A1 (ja) 2002-10-15 2004-04-29 Takeda Pharmaceutical Company Limited イミダゾピリジン誘導体、その製造法および用途
US20070004736A1 (en) 2002-11-22 2007-01-04 Keiji Kubo Imidazole derivative, process for producing the same, and use
EP1597256A1 (en) 2003-02-21 2005-11-23 Pfizer Inc. N-heterocyclyl-substituted amino-thiazole derivatives as protein kinase inhibitors
US6899188B2 (en) * 2003-03-26 2005-05-31 Sunstone Corporation Down hole drilling assembly with concentric casing actuated jet pump
WO2005087266A1 (en) 2004-03-05 2005-09-22 Vddi Pharmaceuticals Combination therapy for inhibition of platelet aggregation
TWI396686B (zh) 2004-05-21 2013-05-21 Takeda Pharmaceutical 環狀醯胺衍生物、以及其製品和用法
US7988933B2 (en) 2006-09-01 2011-08-02 Siemens Healthcare Diagnostics Inc. Identification system for a clinical sample container
KR100906250B1 (ko) 2006-09-04 2009-07-07 주식회사 엘지화학 바인더로서 고중합도 폴리비닐알콜과 폴리비닐피롤리돈의혼합물을 포함하는 전극 합제 및 이를 포함하는 리튬이차전지

Also Published As

Publication number Publication date
MXPA06013243A (es) 2007-02-08
JP4362535B2 (ja) 2009-11-11
JP2008163030A (ja) 2008-07-17
US20100160629A1 (en) 2010-06-24
NZ550985A (en) 2011-02-25
ATE513813T1 (de) 2011-07-15
HK1100666A1 (en) 2007-09-28
RS51925B (sr) 2012-02-29
BRPI0511186A (pt) 2007-12-04
AU2005245298B2 (en) 2011-04-07
EP1748985B1 (en) 2011-06-22
MY154461A (en) 2015-06-30
EP2208726A1 (en) 2010-07-21
EP1748985A1 (en) 2007-02-07
US7745623B2 (en) 2010-06-29
JP4129047B2 (ja) 2008-07-30
WO2005113504A1 (en) 2005-12-01
US20080255362A1 (en) 2008-10-16
CN1989104B (zh) 2011-07-13
EP2208726B1 (en) 2014-08-20
RU2361861C2 (ru) 2009-07-20
PH12012501331A1 (en) 2013-06-17
CN102093285B (zh) 2013-10-16
KR101248637B1 (ko) 2013-03-28
ES2368155T3 (es) 2011-11-14
CN102093285A (zh) 2011-06-15
TW200600508A (en) 2006-01-01
US8697865B2 (en) 2014-04-15
RU2006145449A (ru) 2008-06-27
CN1989104A (zh) 2007-06-27
KR20070021205A (ko) 2007-02-22
US20080255352A1 (en) 2008-10-16
CY1111850T1 (el) 2015-10-07
US20070244118A1 (en) 2007-10-18
IL178896A (en) 2012-07-31
CA2567506A1 (en) 2005-12-01
IL178896A0 (en) 2007-03-08
HRP20110640T1 (hr) 2011-10-31
AU2005245298A1 (en) 2005-12-01
NO20065929L (no) 2007-02-19
CA2567506C (en) 2013-06-18
DK1748985T3 (da) 2011-08-29
SI1748985T1 (sl) 2011-08-31
PT1748985E (pt) 2011-07-29
TWI396686B (zh) 2013-05-21
JP2008500385A (ja) 2008-01-10

Similar Documents

Publication Publication Date Title
IL178896A0 (en) Cyclic amide derivatives, and their production and use as antithrombotic agents
BRPI0712163A2 (pt) composto, e, agente antimicrobiano
CO5580768A2 (es) Derivados de 4,5-diariltiazol como ligandos cb-1
CY1106969T1 (el) Αναστολεις dpp-iv
DK1277736T3 (da) Hidtil ukendte bicykliske forbindelser
ATE478044T1 (de) Biphenylderivate und ihre verwendung bei der behandlung von hepatitis c
GEP20022676B (en) 4-Phenyl-Pyridine Derivatives, Method for Their Production and Their Use for Treatment of Disorders Caused by Antagonist of NK-1 Receptors
PE20070078A1 (es) Compuestos heterociclicos macrociclicos como inhibidores de aspartil proteasa
ATE481387T1 (de) Pyridin-n-oxidverbindungen alsphosphodiesterase-4-inhibitoren
ATE402175T1 (de) 4-oxo-1-(3-substituiertesphenyl)-1,4-dihydro-1, - naphthyridin-3-carbonsäureamide alsphoshodiesterase-4-inhibitoren
MXPA05013631A (es) Derivado heterociclico de metilsulfona.
ATE414516T1 (de) Morphinanderivate als mittel gegen juckreiz
MXPA03011682A (es) Derivados sustituidos de n-acil -anilina, su preparacion y su uso como medicamento.
DE60130766D1 (de) Serotoninwiederaufnahme-inhibitoren
CY1108837T1 (el) ΝΕΑ ΠΑΡΑΓΩΓΑ ΑΜΙΝΟΠΥΡΙΔΙΝΗΣ ΩΣ ΑΝΤΑΓΩΝΙΣΤΕΣ mGluR5
DE60235980D1 (de) Cyclische diaminverbindung mit fünfgliedriger cyclischer gruppe
MXPA03012073A (es) Amidoderivados heterociclicos.
ATE327986T1 (de) Thiophen substituierte amin derivate als glyt-1 inhibitoren
DE60214414D1 (de) Peptidderivat, pharmazeutisch unbedenkliches salz davon, verfahren zu dessen herstellung und dessen verwendung
ATE552003T1 (de) Chinoxalinderivate
ATE148116T1 (de) Piperidin-derivate mit antihistaminischer und antileukomenischer wirkung
DE60330038D1 (de) Neue alpha-ketoamidderivate und deren verwendung
DE69706012D1 (de) N-Acylpiperazinderivat, antibakterielle und gegen Geschwüre wirksame Medikamente
TH58471A3 (th) สารประกอบเฮเทอโรไซคลิคที่เป็นตัวขัดขวางเอนไซม์โรเทเมส
DE69819315D1 (de) Verfahren zur herstellung von piperidincarbonsäureamiden